JB Chem surged 10% today to give a spectacular 190% YOY return & justified Daljeet Kohli’s faith in it. All eyes are now on Capital First to see whether it will also live up to the ace stock picker’s conviction in it and give bumper profits
JB Chemicals has slumped in the wake of its Q4FY14 results which are optically not very encouraging. However, a close study of the results reveals that the poor performance is due to a one-off event and investors must take the opportunity to grab the stock, says Daljeet Kohli
Daljeet Kohli of IndiNivesh has recommended a “Strong Buy” of his latest stock pick Shilpa Medicare. He promises a 50% upside to the stock but from the confidence in his voice it appears there we are looking at a potential multi-bagger here
Prashant Jain of HDFC Mutual Fund knows that the only time investors listen is when the markets are booming. He takes the opportunity to remind them that if they had heeded his advice and bought stocks when the markets were in the doldrums, they would be basking in untold riches today
Evergreen Stock Basket: Stock selection is based on: Longevity Predictability of business cycle Consistent revenue/profit compounder Valuation comfort Product relevance Market share vis-à-vis competition & Earnings growth rate going ahead (Future Prospects). Dark Horses Stock Basket: Stock selection is based on: Deep Valuation Comfort – based on future prospects Longevity Poised to compound faster revenue/profit […]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!